山東華鵬(603021.SH)擬出售“威倫維客”系列商標
格隆匯12月31日丨山東華鵬(603021.SH)公佈,根據整體戰略規劃和經營發展需要,公司與廊坊神州於2020年12月30日簽署了《“威倫維客”品牌買賣合同》,公司擬將“威倫維客”玻璃絲綿系列商標評估後作價4500萬元出售給廊坊神州玻璃棉製品有限公司。本次交易完成後,交易對方同意授權公司繼續使用,預計未來對公司正常生產經營不會產生較大影響,經財務部預計影響公司2020年度淨利潤約4213.44萬元,具體以會計師審計數據為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.